A majority of patients feel lay summaries for clinical trials are very important and won’t participate in future trials if not provided with one...
Featured content
A Summarized Report of the Virtual MedTech EU MDR Exchange...
Session summaries from EUMDR exchange conference 2021.
Latest Content
A Guide to Creating a Robust Patient Engagement Strategy
Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive resource guide. Overcome compliance...
Launch Excellence: The Path Forward for Medical Affairs
Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial data to commercialization with the help of...
How Patient Influencers can Amplify the Pharma Voice
Learn more about patient influencers and their reach and relevance and how you can apply their strategies to your organization.
Why is it Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are viewed in the eyes of the patient.
New Open Data Sharing Policies: WHO and NIH Take Big Steps to...
Making research and data reproducible is vital to improving public health and reinstating trust in science.
Didactic to Dynamic: Innovative Approaches to Deeper Payer...
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create better medical communication materials. Thus...